CEO Schorgl featured in Medical Design & Outsourcing

Peytant's CEO shares insights on navigating the de novo process in recent MD&O article

The latest article by Medical Design & Outsourcing features lessons learned from Peytant's CEO John Schorgl on Peytant's experience navigating the de novo regulatory pathway.

Click here to read more.

← Back to News
Previous
Previous

CEO Schorgl quoted in MD+DI’s look ahead at 2026

Next
Next

Medical Design & Outsourcing features Peytant